various disease states,0.446579
Ratings Network.com reports,-0.224056
email newsletter,0.560435
stage biopharmaceutical company,0.320911
price target,0.271061
email address,0.448938
related companies,0.560435
InvestorPlace Broker Center,0.555736
high fees,-0.735674
biopharmaceutical company,0.433902
research report,0.359277
outperform rating,0.447494
RNN,-0.21548
Zacks Investment Research,0.40995
personal trading style,0.598412
latest news,0.448938
Roth Capital,0.271061
Rexahn Pharmaceuticals Inc.,0.560435
buy rating,0.271061
sexual dysfunction,-0.296807
research offerings,0.40995
proprietary technology platform,0.546893
unmet medical needs,-0.296807
average price,0.270402
concise daily summary,0.448938
Rexahn Pharmaceuticals,0.144976
REXAHN PHARMACTICALS,0.546893
research reports,-0.21548
stock broker,0.245696
clinical stage,0.320911
